Polymorphic variants in TSC1 and TSC2 and their association with breast cancer phenotypes

Fine-scale detection of population-specific linkage disequilibrium using haplotype entropy in the human genome

(2010) Hideaki Mizuno et al.   BMC GENETICS

Therapeutic targeting of mTOR in tuberous sclerosis

(2009) Julian R. Sampson   BIOCHEMICAL SOCIETY TRANSACTIONS

Two Estrogen-Related Variants in CYP19A1 and Endometrial Cancer Risk: A Pooled Analysis in the Epidemiology of Endometrial Cancer Consortium

(2009) V. W. Setiawan et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Genetic polymorphisms of estrogen metabolizing enzyme and breast cancer risk in Thai women

(2009) Suleeporn Sangrajrang et al.   INTERNATIONAL JOURNAL OF CANCER

Targeting the mTOR Signaling Network for Cancer Therapy

(2009) Funda Meric-Bernstam et al.   JOURNAL OF CLINICAL ONCOLOGY

Estrogen promotes the survival and pulmonary metastasis of tuberin-null cells

(2009) Jane J. Yu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Genetic Predisposition to Breast Cancer: Past, Present, and Future

(2008) Clare Turnbull et al.   Annual Review of Genomics and Human Genetics

The TSC1–TSC2 complex: a molecular switchboard controlling cell growth

(2008) Jingxiang Huang et al.   BIOCHEMICAL JOURNAL

Association of genetic polymorphisms of ER-α and the estradiol-synthesizing enzyme genes CYP17 and CYP19 with breast cancer risk in Chinese women

(2008) Lina Zhang et al.   BREAST CANCER RESEARCH AND TREATMENT

The genetics of the p53 pathway, apoptosis and cancer therapy

(2008) Alexei Vazquez et al.   NATURE REVIEWS DRUG DISCOVERY

TP53 Status and Response to Chemotherapy in Breast Cancer

(2008) Philippe Bertheau et al.   PATHOBIOLOGY